BRPI0816513A2 - Composição farmacêutica e método para preparar a suspensão sólida - Google Patents
Composição farmacêutica e método para preparar a suspensão sólidaInfo
- Publication number
- BRPI0816513A2 BRPI0816513A2 BRPI0816513A BRPI0816513A2 BR PI0816513 A2 BRPI0816513 A2 BR PI0816513A2 BR PI0816513 A BRPI0816513 A BR PI0816513A BR PI0816513 A2 BRPI0816513 A2 BR PI0816513A2
- Authority
- BR
- Brazil
- Prior art keywords
- preparing
- pharmaceutical composition
- solid suspension
- suspension
- solid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98118507P | 2007-10-19 | 2007-10-19 | |
| US3894308P | 2008-03-24 | 2008-03-24 | |
| PCT/US2008/080327 WO2009052391A1 (en) | 2007-10-19 | 2008-10-17 | Solid formulations of crystalline compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0816513A2 true BRPI0816513A2 (pt) | 2015-03-24 |
Family
ID=40567797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0816513 BRPI0816513A2 (pt) | 2007-10-19 | 2008-10-17 | Composição farmacêutica e método para preparar a suspensão sólida |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20100222311A1 (pt) |
| EP (1) | EP2214635A1 (pt) |
| JP (1) | JP2011500724A (pt) |
| CN (1) | CN101896161A (pt) |
| AU (1) | AU2008312321A1 (pt) |
| BR (1) | BRPI0816513A2 (pt) |
| CA (1) | CA2702935A1 (pt) |
| IL (1) | IL205130A0 (pt) |
| MX (1) | MX2010004222A (pt) |
| WO (1) | WO2009052391A1 (pt) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| AUPS088702A0 (en) * | 2002-03-04 | 2002-03-28 | Borody, Thomas Julius | Electrolyte purgative |
| EP3424515A3 (en) | 2010-08-04 | 2019-06-19 | Thomas Julius Borody | Stool collection devices and methods for using them |
| AU2011342368B2 (en) | 2010-12-13 | 2016-11-17 | Rite-Prep Pty Ltd | Gastric and colonic formulations and methods for making and using them |
| CA2824639A1 (en) * | 2011-02-17 | 2012-08-23 | Ashish Chatterji | A process for controlled crystallization of an active pharmaceutical ingredient from supercooled liquid state by hot melt extrusion |
| US9968638B2 (en) | 2011-03-09 | 2018-05-15 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
| US9719144B2 (en) | 2012-05-25 | 2017-08-01 | Arizona Board Of Regents | Microbiome markers and therapies for autism spectrum disorders |
| WO2013181694A1 (en) | 2012-06-04 | 2013-12-12 | Gaurav Agrawal | Compositions and methods for treating crohn's disease and related conditions and infections |
| PT2877163T (pt) | 2012-07-27 | 2019-05-24 | Redhill Biopharma Ltd | Formulações e métodos de fabrico de formulações para utilização na evacuação colónica |
| WO2014176632A1 (en) | 2013-04-30 | 2014-11-06 | Borody Thomas J | Compositions and methods for treating microbiota-related psychotropic conditions and diseases |
| AU2014293577B2 (en) | 2013-07-24 | 2017-12-07 | Heartland Consumer Products, Llc | Partial melt co-crystallization compositions |
| US11839698B2 (en) | 2014-03-13 | 2023-12-12 | W. L. Gore & Associates, Inc. | Drug composition and coating |
| HK1254978A1 (zh) | 2015-03-03 | 2019-08-02 | 哈特兰德消费品有限责任公司 | 含萊鮑迪甙d的甜味劑組合物 |
| BR112017024264B1 (pt) | 2015-05-14 | 2022-07-12 | Crestovo Holdings Llc | Composições para transplante de flora fecal e métodos de preparação e utilização das mesmas, e dispositivos para sua administração |
| KR102534545B1 (ko) | 2015-05-22 | 2023-05-18 | 아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 | 자폐 스펙트럼 장애 및 관련된 증상을 치료하는 방법 |
| US10561766B2 (en) | 2015-09-15 | 2020-02-18 | W. L. Gore & Associates, Inc. | Drug composition and coating |
| US11214773B2 (en) | 2015-09-24 | 2022-01-04 | San Diego State University (Sdsu) Foundation | Antibacterial and protective bacteriophage formulations and methods for making and using them |
| US20170360848A1 (en) | 2016-06-15 | 2017-12-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
| US10849936B2 (en) | 2016-07-01 | 2020-12-01 | Regents Of The University Of Minnesota | Compositions and methods for C. difficile treatment |
| US20180036352A1 (en) | 2016-08-03 | 2018-02-08 | Crestovo Holdings Llc | Methods for treating ulcerative colitis |
| WO2018071536A1 (en) | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating primary sclerosing cholangitis and related disorders |
| US10092601B2 (en) | 2016-10-11 | 2018-10-09 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
| WO2018071537A1 (en) | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
| US11040073B2 (en) | 2017-04-05 | 2021-06-22 | Finch Therapeutics Holdings Llc | Compositions and methods for treating diverticulitis and related disorders |
| EP3606541A1 (en) | 2017-04-05 | 2020-02-12 | Crestovo Holdings LLC | Compositions and methods for treating parkinson's disease (pd) and related disorders |
| JP2020521760A (ja) | 2017-05-26 | 2020-07-27 | クレストヴォ・ホールディングス・エルエルシー | 糞便微生物ベースの治療剤を含む凍結乾燥組成物ならびにそれを製造および使用する方法 |
| US10792249B2 (en) | 2017-07-24 | 2020-10-06 | Acryspharm Llc | High drug loading pharmaceutical compositions |
| JP2020530494A (ja) | 2017-08-07 | 2020-10-22 | フィンチ セラピューティクス、インコーポレイテッド． | 健康な腸バリアを維持及び回復するための組成物及び方法 |
| ES2900457T3 (es) * | 2018-01-12 | 2022-03-17 | Tiefenbacher Alfred E Gmbh & Co Kg | Formulación de comprimidos y cápsulas que contienen pirfenidona |
| US11166990B2 (en) | 2018-07-13 | 2021-11-09 | Finch Therapeutics Holdings Llc | Methods and compositions for treating ulcerative colitis |
| EP3856212A1 (en) | 2018-09-27 | 2021-08-04 | Finch Therapeutics Holdings LLC | Compositions and methods for treating epilepsy and related disorders |
| AU2019360377A1 (en) | 2018-10-17 | 2021-04-29 | Sandoz Ag | Co-crystals comprising levothyroxine and a dicarboxylic acid |
| EP3883548A4 (en) | 2019-04-08 | 2022-11-09 | Cosci Med-tech Co. Ltd. | METHODS FOR IMPROVING THE SOLUBILIZATION OF PHARMACEUTICAL SUBSTANCES AND PRODUCTS THEREOF |
| PH12021553137A1 (en) | 2019-07-19 | 2022-07-25 | Finch Therapeutics Holdings Llc | Methods and products for treatment of gastrointestinal disorders |
| BR112023003114A2 (pt) * | 2020-09-03 | 2023-04-04 | Philip Morris Products Sa | Composições em pó ativas de baixa higroscopicidade liofilizadas |
| US12605388B2 (en) | 2024-09-25 | 2026-04-21 | Azurity Pharmaceuticals Ireland Limited | Lamotrigine salts, co-crystals, and compositions |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4310543A (en) * | 1980-10-09 | 1982-01-12 | Hoffmann-La Roche Inc. | Prostaglandin compositions |
| US4525339A (en) * | 1982-10-15 | 1985-06-25 | Hoffmann-La Roche Inc. | Enteric coated oral dosage form |
| US4476248A (en) * | 1983-02-28 | 1984-10-09 | The Upjohn Company | Crystallization of ibuprofen |
| US4892742A (en) * | 1985-11-18 | 1990-01-09 | Hoffmann-La Roche Inc. | Controlled release compositions with zero order release |
| US5190748A (en) * | 1988-11-22 | 1993-03-02 | Hoffmann-La Roche Inc. | Absorption enhancement of antibiotics |
| US5075291A (en) * | 1989-11-22 | 1991-12-24 | Ici Americas Inc. | Crystalline sugar alcohol containing uniformly dispersed particulate pharmaceutical compound |
| HUT59653A (en) * | 1990-11-15 | 1992-06-29 | Puetter Medice Chem Pharm | Process for producing complexes containing s/+/-phenyl-alcanoic acids and alpha-hydroxy-alcanoic acids and pharmaceutical compositions containing them as active components |
| US5318781A (en) * | 1993-04-06 | 1994-06-07 | Hoffmann-La Roche Inc. | Absorption enhancement of antibiotics |
| US5393765A (en) * | 1993-12-13 | 1995-02-28 | Hoffmann-La Roche Inc. | Pharmaceutical compositions with constant erosion volume for zero order controlled release |
| US6008228A (en) * | 1995-06-06 | 1999-12-28 | Hoffman-La Roche Inc. | Pharmaceutical compositions containing proteinase inhibitors |
| US6350786B1 (en) * | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
| US6482847B2 (en) * | 2000-10-03 | 2002-11-19 | Hoffmann-La Roche Inc. | Amorphous form of cell cycle inhibitor having improved solubility and bioavailability |
| CN1255185C (zh) * | 2001-05-03 | 2006-05-10 | 弗·哈夫曼-拉罗切有限公司 | 无定形甲磺酸奈非那韦的药物剂型 |
| CN100594023C (zh) * | 2003-02-03 | 2010-03-17 | 诺瓦提斯公司 | 药物制剂 |
| MXPA06003813A (es) * | 2003-10-10 | 2006-06-14 | Lifecycle Pharma As | Forma solida de dosificacion que comprende un fibrato y una estatina. |
| EP1744757A4 (en) * | 2004-05-04 | 2009-04-22 | Equitech Corp | IMPROVED ENHANCED COMPOSITION |
-
2008
- 2008-10-17 CA CA2702935A patent/CA2702935A1/en not_active Abandoned
- 2008-10-17 CN CN2008801202412A patent/CN101896161A/zh active Pending
- 2008-10-17 BR BRPI0816513 patent/BRPI0816513A2/pt not_active IP Right Cessation
- 2008-10-17 EP EP08839405A patent/EP2214635A1/en not_active Withdrawn
- 2008-10-17 MX MX2010004222A patent/MX2010004222A/es not_active Application Discontinuation
- 2008-10-17 WO PCT/US2008/080327 patent/WO2009052391A1/en not_active Ceased
- 2008-10-17 JP JP2010530145A patent/JP2011500724A/ja not_active Withdrawn
- 2008-10-17 US US12/682,938 patent/US20100222311A1/en not_active Abandoned
- 2008-10-17 AU AU2008312321A patent/AU2008312321A1/en not_active Abandoned
-
2010
- 2010-04-15 IL IL205130A patent/IL205130A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008312321A1 (en) | 2009-04-23 |
| CA2702935A1 (en) | 2009-04-23 |
| IL205130A0 (en) | 2010-11-30 |
| JP2011500724A (ja) | 2011-01-06 |
| US20100222311A1 (en) | 2010-09-02 |
| WO2009052391A1 (en) | 2009-04-23 |
| EP2214635A1 (en) | 2010-08-11 |
| CN101896161A (zh) | 2010-11-24 |
| MX2010004222A (es) | 2010-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0816513A2 (pt) | Composição farmacêutica e método para preparar a suspensão sólida | |
| BRPI0815138A2 (pt) | Métodos e organismos para a produção acoplada a crescimento de 1,4-butanodiol | |
| BRPI0818430A2 (pt) | Composição antiperspirante sólida e método para a produção da mesma | |
| BRPI0912384A2 (pt) | composição, e, método para preparar uma composição | |
| BRPI0814153A2 (pt) | "método para preparar um composto e composto" | |
| BRPI0919199A2 (pt) | suspensões farmacêuticas submicrométricas estabilizadas e métodos para preparas as mesmas | |
| BRPI0817727A2 (pt) | composição de graxa lubrificante, e, método para preparar uma composição de graxa | |
| GB2456752B (en) | Agrochemical composition and method for preparing the same | |
| BRPI0909691A8 (pt) | composto, método para preparar um composto, e, composição farmacêutica | |
| BRPI0813774B8 (pt) | produto microencapsulado, método para preparar o mesmo, e, produto consumível | |
| BRPI0814611A2 (pt) | Composição, processo para preparar uma composição, e, uso de uma composição | |
| BRPI0819020A2 (pt) | "método e sistema para criar uma peça" | |
| FI20075533L (fi) | Hiomatuote ja menetelmä tämän valmistamiseksi | |
| BRPI0919466A2 (pt) | composição farmacêutica para liberação modificada | |
| BRPI0721651A2 (pt) | Composição farmacêutica | |
| BRPI0914918A2 (pt) | forma de dosagem farmacêutica, e, método para preparar uma forma de dosagem sólida. | |
| BR112012002102A2 (pt) | composição farmaceutica e metodo para preparar uma composição farmaceutica | |
| BRPI0812647A2 (pt) | "composição e método para produzir a composição" | |
| BRPI0807220B1 (pt) | composição, e, métodos para aumentar a força de compressão de uma composição e para aumentar a retenção de fragrância de uma composição | |
| BRPI0818483A2 (pt) | Método para preparar uma composição farmacêutica, composição farmacêutica, e, uso da mesma. | |
| BRPI0720530A2 (pt) | Partícula, processo para preparar a partícular, e, composição | |
| IL201248A (en) | 18f-labelled compounds and methods for preparing the same | |
| PT2209464E (pt) | Composição farmacêutica antimalárica | |
| BRPI0720705A2 (pt) | Método para preparar uma composição de espumação, e, composição de espumação | |
| BRPI0807001A2 (pt) | Formulação farmacêutica, e, método para preparação de uma formulação farmacêutica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |